Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT01106495

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01106495
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01106495. Randomized; single masking; primary purpose treatment. Start 2010-05 (actual); primary completion 2018-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis
Acronym
SESA
Condition
Atherosclerosis
Intervention (Device)
Enhanced External Counterpulsation (EECP)
Intervention (Drug)
Simvastatin
Lead sponsor
Sun Yat-sen University (class: other)

Record details

Record id
cardio:ct-nct01106495
Content hash
2e72bcd0055248b562575152df3a3c3bf849590e8e10e69969ff1a2e6124e756